DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
Keywords: Brachytherapy
| MO-E115-BOP-F1-2 | Patient Dosimetry Statistics From Permanent Cs-131 Low Dose Rate Brachytherapy Implants in the Brain A Turner*, D Brachman, GT Medical Technologies, Inc, Phoenix, AZ |
| MO-G-BRA-0 | Recent Task Group Reports On Brachytherapy: TG-222 and TG-303 H Zhang1*, W Feng2*, K Hwang3*, J Zoberi4*, (1) Northwestern Memorial Hospital, Chicago, IL, (2) Saint Barnabas Medical Center, Tenafly, NJ, (3) UT MD Anderson Cancer Center, Sugar Land, TX, (4) Washington University School of Medicine, Saint Louis, MO |
| MO-G-BRA-1 | Introduction H Zhang1*, W Feng2*, K Hwang3*, J Zoberi4*, (1) Northwestern Memorial Hospital, Chicago, IL, (2) Saint Barnabas Medical Center, Tenafly, NJ, (3) UT MD Anderson Cancer Center, Sugar Land, TX, (4) Washington University School of Medicine, Saint Louis, MO |
| MO-G-BRA-2 | Mesh Brachytherapy Planning Techniques and Dosimetric Parameters H Zhang1*, W Feng2*, K Hwang3*, J Zoberi4*, (1) Northwestern Memorial Hospital, Chicago, IL, (2) Saint Barnabas Medical Center, Tenafly, NJ, (3) UT MD Anderson Cancer Center, Sugar Land, TX, (4) Washington University School of Medicine, Saint Louis, MO |
| MO-G-BRA-3 | Mesh Brachytherapy Quality Management and Medical Event Definition H Zhang1*, W Feng2*, K Hwang3*, J Zoberi4*, (1) Northwestern Memorial Hospital, Chicago, IL, (2) Saint Barnabas Medical Center, Tenafly, NJ, (3) UT MD Anderson Cancer Center, Sugar Land, TX, (4) Washington University School of Medicine, Saint Louis, MO |
| MO-G-BRA-4 | Protocol Development and MRI Basics for the Implementation of MRI in High Dose Rate Brachytherapy H Zhang1*, W Feng2*, K Hwang3*, J Zoberi4*, (1) Northwestern Memorial Hospital, Chicago, IL, (2) Saint Barnabas Medical Center, Tenafly, NJ, (3) UT MD Anderson Cancer Center, Sugar Land, TX, (4) Washington University School of Medicine, Saint Louis, MO |
| MO-G-BRA-5 | Applicator Commissioning and Workflow Development for the Implementation of MRI in High Dose Rate Brachytherapy H Zhang1*, W Feng2*, K Hwang3*, J Zoberi4*, (1) Northwestern Memorial Hospital, Chicago, IL, (2) Saint Barnabas Medical Center, Tenafly, NJ, (3) UT MD Anderson Cancer Center, Sugar Land, TX, (4) Washington University School of Medicine, Saint Louis, MO |
| MO-G-BRA-6 | Q & A H Zhang1*, W Feng2*, K Hwang3*, J Zoberi4*, (1) Northwestern Memorial Hospital, Chicago, IL, (2) Saint Barnabas Medical Center, Tenafly, NJ, (3) UT MD Anderson Cancer Center, Sugar Land, TX, (4) Washington University School of Medicine, Saint Louis, MO |
| MO-H345-IePD-F6-3 | Characterization of Fluoroscopy Radiation Dose Associated with the Administration of Y-90 Microspheres for Radioembolization Therapy X Nie*, K Recca, J Zhang, University of Kentucky, Lexington, KY |
| PO-GePV-E-12 | Physicist Brachytherapy Training in 2021 - A Survey of Therapeutic Medical Physics Residency Program Directors M Aima1*, S Simiele2, S Richardson3, C S Melhus4, (1) Stanford University, Stanford, CA, (2) MD Anderson Cancer Center, Houston, TX, (3) Swedish Medical Center-Tumor Institute, Seattle, WA, (4) Tufts Medical Center, Boston, MA |
| PO-GePV-I-53 | MATU-Net: A Deep Learning-Based Pipeline for Auto Segmentation of Pelvic Lymph Nodes During Brachytherapy of Locally Advanced Cervical Cancer E Showkatian1*, Z Siavashpour2, S Sadeghi3, (1) Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran, (2) Department of Radiotherapy Oncology, Shohada-e Tajrish Medical Center, School of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran, (3) Department of Nuclear Physics, Faculty of Sciences, University of Mazandaran, Babolsar, Iran |
| PO-GePV-M-182 | Automated Multimodality Image Registration for Application in Brachytherapy Using U-Net Based Organ Segmentation K Qing1*, X Feng2, 3, S Glaser1, W Watkins1, D Du1, Y Chen1, C Han1, J Liang1, J Liu1, B Liu1, Q Chen1, A Liu1, (1) City of Hope National Medical Center, Duarte, CA, (2) University of Virginia, Charlottesville, VA, (3) Carina Medical LLC, Lexington, KY |
| PO-GePV-M-259 | Commissioning Elekta Unity MR Imaging Sequences for MRI-Guided Brachytherapy W Massock*, Y Kim, J St-Aubin, University of Iowa, College of Medicine, Iowa City, IA |
| PO-GePV-P-17 | Evaluation of Fractional Variations of Delineated Volumes and Dosimetric Parameters for Patients Treated with HDR Multi-Channel Vaginal Cylinders T Giaddui*, B Wang, J Price, C Heese, C Miyamoto, B Micaily, S Li, Temple University Hospital, Phila., PA |
| PO-GePV-T-14 | Comparison Between Partition Model and 3D Dosimetry for 90Y-Microspheres Treatment Based On 99Tc-MAA_SPECT Examination M Wong*, F Lee, Queen Elizabeth Hospital, Hong Kong, Kowloon, Hong KongHK, |
| PO-GePV-T-18 | Commission a 3D Printed Applicator System for Skin Brachytherapy Treatment M Ashenafi, K Aujla, D Zheng*, University of Rochester, Rochester, New York |
| PO-GePV-T-19 | Automated Physics Chart Checking for Brachytherapy H Xu*, M MacFarlane, M Guerrero, A Gopal, S Chen, B Zhang, University of Maryland School of Medicine, Baltimore, MD |
| PO-GePV-T-20 | Miniaturized Scintillator Detector for in Vivo Dosimetry in HDR Brachytherapy M Gonod1, M Suarez2, C CHACON3, J Crouzilles4, S Laskri5, J Vinchant6, T Grosjean7, L Marage8*, (1) Centre Georges-Francois Leclerc, Dijon, 21, FR, (2) FEMTO-ST Institute - University of Bourgogne Franche-Comte, Besancon, ,FR, (3) FEMTO-ST Institute - University of Bourgogne Franche-Comte, Besancon, 25, FR, (4) SEDI-ATI Fibres Optiques, Evry-courcouronnes, ,FR, (5) SEDI-ATI Fibres Optiques, Evry-courcouronnes, FR, (6) SEDI-ATI Fibres Optiques, Evry-courcouronnes, FR, (7) FEMTO-ST Institute - University of Bourgogne Franche-Comte, Besancon, FR, (8) Dijon, 21, FR |
| PO-GePV-T-22 | An Autoradiograph-Free Method for the Commissioning and QA of Elekta Interstitial MR/CT HDR Tandem and Ring Applicators J Wu*, A Schwarz, S Sun, L Maloney, G Yan, B Lu, University of Florida, Gainesville, FL |
| PO-GePV-T-23 | A Novel Quality Assurance System to Evaluate MR-Only Workflow for Interstitial and Intracavitary Gynecological HDR Brachytherapy S Aldelaijan1,2*, H Alsaleh1, C Constantinescu1, S Devic2, I Buzurovic3, B Moftah1,2, (1) King Faisal Hospital & Research Centre, Riyadh, SA, (2) Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, CA, (3) Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA |
| PO-GePV-T-24 | Utilization of Phosphorescent Materials During Quality Assurance of HDR Afterloaders D Sterling*, E Ehler, X Tang, D Mathew, University of Minnesota, Minneapolis, MN |
| PO-GePV-T-26 | Development of An Original Multi-Modality Gynecologic Brachytherapy Phantom B Eckroate1*, J Raffi2, R Venkataraman3, Y Kim4, D Ayala-peacock5, O Craciunescu6, (1) Duke University, Durham, NC, (2) Duke University Medical Center, Durham, NC, (3) Eigen Health Services Llc, Grass Valley, CA, (4) Duke University Medical Center, Durham, NC, (5) Duke University Medical Center, Durham, NC, (6) Duke University Medical Center, Durham, NC |
| PO-GePV-T-27 | Impact of SAVI Catheter Digitization Variability On Dosimetric Parameters of HDR Brachytherapy Breast Treatment Plans V Chaswal*, M Morcos, T Romaguera, U Abraham, S George, J McCulloch, A Llanes Lopez, J Contreras, M Rodrigues, A Gutierrez, R Tolakanahalli, Miami Cancer Institute, Miami, Florida |
| PO-GePV-T-31 | Optimisation of Point A Based Cervix Cancer HDR Brachytherapy S Acharya1*, (1) Assam Cancer Care Foundation, Lakhimpur, Assam, IN |
| PO-GePV-T-32 | Source Position Uncertainty in the Venezia Advanced Gynecological Applicator for High-Dose-Rate Brachytherapy X Li*, Y Huang, K Hopfensperger, S Bhagroo, H Zhao, J Kunz, G Nelson, F Su, University of Utah, Salt Lake City, UT |
| PO-GePV-T-34 | Evaluation of the Dosimetric Quality of MRI-Only HDR Brachytherapy Planning with Titanium Ring-And-Tandem Applicators I Veltchev*, T Lin, X Chen, R Price, K Howell, C Ma, Fox Chase Cancer Center, Philadelphia, PA |
| PO-GePV-T-37 | Are We Improving? The Learning Curve for Implementing Intraoperative Ultrasound-Guided Prostate High Dose Rate (HDR) Brachytherapy A Besemer1*, J Wong1, S Wang1, M Hyun1, S Wisnoskie1, D Schott1, D Zheng1,2, Y Lei1,3, K Gallagher1, S Hendley1, (1) University of Nebraska Medical Center, Omaha, NE, (2) University of Rochester, Rochester, NY, (3) Barrow Neurological Institute, Phoenix, AZ |
| PO-GePV-T-38 | Probability of Radiation Induced Maculopathy and Optic Neuropathy Following I-125 Eye Plaque Brachytherapy M Studenski1*, V Peters2, A Gurayah2, W Jin1, D Kwon3, W Zhao3, Z Correa4, J Harbour5, S Samuels1, (1) Department of Radiation Oncology, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, (2) University Of Miami Miller School Of Medicine, Miami, FL, (3) Department of Biostatistics and Bioinformatics, University Of Miami Miller School Of Medicine, Miami, FL, (4) Department of Ophthalmology, University of Miami Bascom Palmer Eye Institute, Miami, FL, (5) Department of Ophthlmology, UT Southwestern Medical Center, Dallas, TX |
| PO-GePV-T-39 | Dose Reduction and Tumor Coverage in Small Uveal Melanoma Tumors Treated with Eye Plaque Brachytherapy When Normalizing to An Alternative Prescription Point S Tan*, E Schnell, D Zuro, S Ahmad, S Martinez, University of Oklahoma Health Sciences Center, Oklahoma City, OK |
| PO-GePV-T-49 | Radiobiological Comparison of Prostate LDR Brachytherapy with and Without Simultaneously Integrated Boost to the Dominant Intra-Prostatic Lesion Defined by 68Ga-PSMA PET / MpMRI R Holden*, J Lian, S To, T Royce, P Mavroidis, University of North Carolina, Chapel Hill, NC |
| PO-GePV-T-51 | Effects of Multichannel Cylinder System (MCC) Rotation On Plan Robustness in Asymmetric Vaginal Tumors L Huang*, E Suarez, Z Wang, M Naik, J Greskovich, T Djemil, Cleveland Clinic Florida, Weston, FL |
| PO-GePV-T-55 | Integrated Optimization of Needle Path and Dwell Time for Individual Template Guided Interstitial Brachytherapy Y Wang1, B Liu1,2*, H Sun3, F Zhou1,2 (1)Image Processing Center, Beihang University, Beijing, CN (2) Beijing Advanced Innovation Center for Biomedical Engineering, Beihang University, Beijing, CN (3) Department of Radiation Oncology, Peking University Third Hospital, Beijing, CN |
| PO-GePV-T-57 | Simulating Seed Carrier Resorption to Generate Carrier-Specific TG-43 Tables for Post-Permanent Implant Dosimetry M Trager*, D Aramburu Nunez, A Damato, G Cohen, Memorial Sloan Kettering Cancer Center, New York, NY |
| PO-GePV-T-58 | Better Identification of Dose Constraints for Use in HDR in the Treatment of Locally Advanced Cervix Cancer S Choudrie*, R Crilly, J Kahn, Oregon Health & Science Univ, Portland, OR |
| PO-GePV-T-60 | Monte Carlo Simulation of the 224Ra Decay Chain and the Diffusion of 220Rn for Diffusing Alpha-Emitters Radiotherapy V Diaz Martinez1,2*, L Carroll1,2, S Abbasinejad Enger1,2 (1) Medical Physics Unit, Department of Oncology, Faculty of Medicine, McGill University, Montreal, Quebec, CA (2) Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada |
| PO-GePV-T-204 | Implementation of a Daily QA Program for Clinically-Deployed Custom Software in Radiation Oncology Z Iqbal*, R Cardan, R Popple, C Cardenas, University of Alabama - Birmingham, Birmingham, AL |
| SU-E-206-6 | Towards Automated, Knowledge-Based Brachytherapy Treatment Planning: Converting 3D Dose to Optimized Dwell Times K Kallis, L Moore, D Brown, J Mayadev, KL Moore, SM Meyers*, University of California, San Diego, La Jolla, CA |
| SU-E-BRA-7 | Towards Improved Robustness to Needle Displacement: A Robust Planning Technique for Gynecological High Dose Rate Interstitial Brachytherapy K Jiang*, M MacFarlane, R McCarroll, N Lamichhane, P Mohindra, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD |
| SU-H300-IePD-F4-1 | Sub-Second D(M,M) Calculation for LDR Prostate Brachytherapy Using Deep Learning Methods Francisco Berumen-Murillo1,2*, Shirin Abbasinejad Enger3,4, Luc Beaulieu1,2, (1) Departement de physique, genie physique et optique et Centre de recherche sur le cancer, Universite Laval, Quebec, QC, CA, (2) CHU De Quebec - Universite Laval, Quebec, QC, CA, (3) Medical Physics Unit, Department of Oncology, McGill University, Montreal, QC, CA, (4) Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, CA |
| SU-H300-IePD-F7-1 | Medical Physics Residents Enjoy Brachytherapy Training and Demand More! S Simiele1*, M Aima2, C Melhus3, S Richardson4, (1) MD Anderson Cancer Center, Houston, TX, (2) Stanford University, Los Altos, CA, (3) Tufts Medical Center, Boston, MA, (4) Swedish Medical Center-Tumor Institute, Seattle, WA |
| SU-H300-IePD-F7-2 | Predicting Benefit for Hybrid Tandem and Needle Applications in the Treatment of Cervical Cancer with Brachytherapy WT Watkins1*, YJ Chen1, S Glaser1, (1) City Of Hope National Medical Center, Duarte CA 91010 |
| SU-H300-IePD-F7-3 | An Automatic Needle and Seed Planning Algorithm for Head and Neck Seed Implant Brachytherapy Z Xiao1,F Zhou1,2, B Liu1,2*, Z Ji3, H Sun3, Y Jiang3, J Wang3, Q Wu4, (1) Image Processing Center, Beihang University, Beijing, CN (2) Beijing Advanced Innovation Center for Biomedical Engineering, Beihang University, Beijing, CN (3) Department of Radiation Oncology, Peking University Third Hospital, Beijing, CN (4) Duke University Medical Center, Durham, NC |
| SU-H300-IePD-F7-5 | A Deep Convolutional Neural Network Based Dose Engine for Seed Implant Brachytherapy T Xiong1, L Geng1, F Zhou2,3, B Liu2,3*, Q Wu4, (1) School of Physics, Beihang University, Beijing, CN (2) Image Processing Center, Beihang University, Beijing, CN (3) Beijing Advanced Innovation Center for Biomedical Engineering, Beihang University, Beijing, CN (4) Duke University Medical Center, Durham, NC |
| SU-H330-IePD-F7-1 | A Knowledge-Based Machine Learning Model for DVH Prediction in HDR Brachytherapy Z Li1, B Zhou1*,Q Zhu1, Z Li1, J Fu1, Z Yang2, (1) Shanghai Sixth People's Hospital, Shanghai, Shanghai, CN, (2) Duke University, Durham, NC |
| SU-H330-IePD-F7-4 | Cross Comparison and Validation of Metallic Catheter Reconstruction for Use in High-Dose-Rate Brachytherapy Utilizing Electromagnetic Tracker, Ultrasound, and Computed Tomography Information N Hassan Rezaeian*, G Cohen, D Aramburu Nunez, J Beaudry, P McCann, A Damato, Memorial Sloan Kettering Cancer Center, New York, NY |
| SU-H330-IePD-F7-5 | Clinical Outcome-Driven Intelligent Automatic Treatment Planning of High-Dose-Rate Brachytherapy for Cervical Cancer E Wang, C Shen*, Y Gonzalez, X Jia, The University of Texas Southwestern Medical Center, Dallas, TX |
| SU-H400-IePD-F7-1 | Feasibility of HDR Brachytherapy Applicator Commissioning and QA Using a Mobile CT Scanner M Stock*, Y Vinogradskiy, R Taleei, Thomas Jefferson University, Philadelphia, PA |
| SU-H400-IePD-F7-2 | Systematic Review On the Use of Artificial Intelligence in Brachytherapy J Theeler1, Y Kim2*, University Of Iowa, (1) Biomedical Engineering Department,(2) Radiation Oncology Department, Iowa City, Iowa, USA |
| SU-H400-IePD-F7-3 | Investigating Applicator Effect On the Depth-Dose Distribution of a Novel Y-90 Disc Source with 3D-Printed Film Dosimetry Tools L Huang*, X Chang, J Chang, J Liu, Y Cao, Northwell Health, Lake Success, NY |
| SU-I400-BReP-F3-1 | Quantitative Prospective Evaluation of Automated Contouring for HDR Gynecologic Brachytherapy Z Iqbal*, S Marcrom, R Cardan, A Kraus, K Lee, A Mcclain, R Popple, C Cardenas, University of Alabama - Birmingham, Birmingham, AL |
| SU-K-207-1 | Comparing Spatial Accuracy of Catheter Localization Between Stepping-Transverse Mode and Twister-Sagittal Mode in Transrectal Ultrasound (TRUS) Based High-Dose-Rate (HDR) Brachytherapy for Prostate Cancer Therapy M Keohane1*, S Dieterich1, J Matney1, P Beagen1, J Zhao1, R Valicenti1, T Liu2, S Benedict1, P Park1, (1) UC Davis Medical Center, Sacramento, CA,(2) Emory Univ, Atlanta, GA, |
| SU-K-207-3 | Development of a Novel MRI-Compatible Applicator for Intensity Modulated Rectal Brachytherapy A Thibodeau-Antonacci1, T Vuong2, B Liontis3, F Rayes3, S Pande4, S Abbasinejad Enger1,4 (1) Medical Physics Unit, Department of Oncology, McGill University, Montreal, Quebec, CA (2) Department of Radiation Oncology, Jewish General Hospital, McGill University, Montreal, Quebec, Ca (3) Pega Medical, Laval, Quebec, Ca (4) Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Ca |
| SU-K-207-6 | Image Registration of An EMT-Enabled Afterloader and CT Scan: A Phantom Study I.N Gomez-Sarmiento1*, D Tho1, W de Jager3, D Laurendeau2, L Beaulieu1, (1) CHU de Quebec - Universite Laval, Quebec, QC, CA, (2) Electrical and Computer Engineering, Faculty of Science and Engineering, Universite Laval, Quebec, QC, CA, (3) Elekta Brachytherapy, Veenendaal, The Netherlands |
| SU-K-207-8 | BEST IN PHYSICS (THERAPY): Optimization of Permeability and Currie Temperature for Higher Heat Generation in the Innovative Thermo-Brachytherapy Seed S Taghizadehghahremanloo*, D Shvydka, E Parsai, University of Toledo Medical Center, Toledo, OH |
| TU-AB-BRA-0 | Emerging and Re-Emerging Brachytherapy Treatments A Damato1*, S Abbasinejad Enger2*, K Roberts3*, J Prisciandaro4*, D Han5*, D Aramburu Nunez6*, (1) Memorial Sloan Kettering Cancer Center, New York, NY, (2) McGill University, Montreal, QC, CA, (3) Yale University, New Haven, CT, (4) University of Michigan, Ann Arbor, MI, (5) Yale University, Woodbridge, CT, (6) New York, NY |
| TU-D1000-IePD-F7-1 | Deep Learning-Based Automatic Segmentation Framework for Targets and OARs in Cervical High Dose Rate (HDR) Brachytherapy R Ni1*, S Kim1, B Haibe-kains1, A Rink1,2, (1) University of Toronto, Toronto, ON, CA, (2) Princess Margaret Hospital, Toronto, ON, CA |
| TU-F115-IePD-F6-3 | An Estimate of Fetal Dose From Permanent Cs-131 Brachytherapy Implants in the Brain A Turner1*, C Ferreira2, (1) GT Medical Technologies, Inc, Phoenix, AZ, (2) University of Minnesota, Minneapolis, MN |
| TU-I345-IePD-F2-4 | Deep-Learning Based Automated Contouring, Dose-Prediction, and Planning in High-Dose-Rate Prostate Brachytherapy C V Guthier1,2*, T C Harris1, D A O'Farrell3, S A Friesen4, M T King5, I M Buzurovic6, R A Cormack7, (1) Department of Radiation Oncology, Brigham and Womens Hospital/Dana-Farber Cancer Institute and Harvard Medical School, Boston MA (2) Artificial Intelligence in Medicine (AIM) Program at Harvard-MGB |
| WE-C930-IePD-F4-1 | A Comparison of Monte Carlo and TG-43 Calculated Doses for Cesium-131 Implants Used to Treat Recurrent Head and Neck Cancer V Desai*, R Taleei, Thomas Jefferson University Hospital, Philadelphia, PA |
| WE-E-BRA-2 | Analysis of a Novel Concept for Intraocular Tumors - the Combination of Brachytherapy and Teletherapy H Manke1*, D Fluehs2, M Stroth1, S Mueller1, B Spaan1, J Albrecht1, (1) TU Dortmund University, Dortmund, DE, (2) University Hospital Essen, Essen, DE |
| WE-E-BRA-4 | MRI-Only Treatment Planning (MRTP) for Interstitial Gynecologic HDR Brachytherapy C Lee*, E Kaza, T Harris, D O'Farrell, R Cormack, I Buzurovic, Department of Radiation Oncology, Dana-Farber/Brigham and Womens Cancer Center, Harvard Medical School, Boston, MA |